Zobrazeno 1 - 10
of 68
pro vyhledávání: '"59"'
Autor:
Hiroki Ishihara, Takashi Ikeda, Hiroaki Shimmura, Toshio Takagi, Hideki Ishida, Kazunari Tanabe, Junpei Iizuka, Kazutaka Nakamura, Hidekazu Tachibana, Kazuhiko Yoshida, Hirohito Kobayashi, Hironori Fukuda, Yasunobu Hashimoto, Tsunenori Kondo, Yuki Nemoto
Publikováno v:
Targeted Oncology. 16:493-502
It remains unclear how early treatment interruption of nivolumab plus ipilimumab due to immune-related adverse events affects the outcome of previously untreated metastatic renal cell carcinoma (mRCC). To investigate the prognostic impact of the earl
Autor:
Bastiana Piras, Andrea Marongiu, Luciana Mele, Giuseppe Madeddu, Angela Spanu, Susanna Nuvoli, Ilaria Gelo
Publikováno v:
BMC Cancer
BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
BackgroundThe identification of neck lymph node (LN) metastases represents a very important issue in the management of patients with differentiated thyroid carcinoma (DTC). To this purpose, in the present study, we used 131I-SPECT/CT as a diagnostic
Autor:
Jeong Hoon Lee, Hyo Young Lee, Yun Bin Lee, Eun Ju Cho, Joon Hyeok Lee, S.-W. Kim, Jun Sik Yoon, Jung Hwan Yoon, Su Jong Yu, Young Chang, Yoon Jun Kim, Byeong Geun Song, Dong Hyun Sinn
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-10 (2019)
BMC Cancer
BMC Cancer
Background Several randomized controlled trials have shown that adjuvant immunotherapy with autologous cytokine-induced killer (CIK) cells prolongs recurrence-free survival (RFS) after curative treatment for hepatocellular carcinoma (HCC). We investi
Autor:
Danielle Bagarry-Liegey, Bruno Lacarelle, Rose-Marie Ferri-Dessens, Florence Duffaud, M. Zanaret, Nicolas Frances, Cédric Mercier, Antoine Giovanni, Jean-François Seitz, Arthur Varoquaux, Hafedh Marouani, Joseph Ciccolini, Caroline Brunet, A. Blesius, Roger Favre, Mohamed Chefrour, Chen Guang Yang, Laetitia Dahan
Publikováno v:
Cancer Chemotherapy and Pharmacology. 67:49-56
Fluoropyrimidine drugs are widely used in head and neck cancer (HNC). DPD deficiency is a pharmacogenetics syndrome associated with severe/lethal toxicities upon 5-FU or capecitabine intake. We have developed a simple, rapid, and inexpensive function
Publikováno v:
Medical Oncology. 27:632-639
Abelson interactor protein-1 (ABI1) is a promising candidate tumor suppressor, and plays critical roles both in the pathogenesis of BCR-Abl-induced leukemia and in the spread of several solid tumors. The expression of ABI1 and its role in cancer prog
Publikováno v:
Medical Oncology. 31
Aberrant methylation of CHFR (Checkpoint with forkhead associated and ring finger) gene was frequently happened in cancer and had been reported to be associated with the sensitivity of microtubule inhibitors in several cancer cells containing gastric
Autor:
Martha A. Zeiger, Zhiyang Liu, Brittany A. McKelvey, Leslie Cope, Christopher B. Umbricht, Yongchun Wang, Lisa M. Rooper
Publikováno v:
J Cancer Res Clin Oncol
BACKGROUND: While molecular testing is a promising strategy for preoperative assessment of cytologically indeterminate thyroid nodules, thyroid fine needle aspiration biopsy (FNA) presents unique challenges for molecular assays, including contaminati
Autor:
Motohiro Fujiwara, Yoshinobu Komai, Shinya Yamamoto, Ryo Fujiwara, Tomohiko Oguchi, Noboru Numao, Shotaro Yasuoka, Junji Yonese, Takeshi Yuasa
Publikováno v:
Cancer Chemotherapy and Pharmacology. 88:525-531
In this study, we investigated the association between the early response of serum and hematological variables and the outcome of cabazitaxel therapy. The medical records of 59 consecutive patients who had previously received docetaxel chemotherapy f
Autor:
Haonan Lu, Katherine Nixon, Eric O. Aboagye, Natasha Rinne, Christina Fotopoulou, Paula Cunnea
Publikováno v:
British Journal of Cancer
Background: Maximal effort cytoreductive surgery is associated with improved outcomes in advanced high-grade serous ovarian cancer (HGSOC). However, despite complete gross resection (CGR), there is a percentage of patients who will relapse and die ea
Autor:
Ericka M. Ebot, Sarki A. Abdulkadir, Michael C. Burns, Garrett M. Frampton, Maha Hussain, Jeffrey S. Ross, Zachary R. Chalmers
Publikováno v:
Prostate Cancer Prostatic Dis
BACKGROUND: Men with early-onset prostate cancer are at increased risk for cancer-related mortality, yet the prevalence and spectrum of molecular alterations in this patient population is unknown. Here, we analyze comprehensive genomic profiling data